Allergy/Immunology — Medicare Part B billing by state
417 physician groups whose primary specialty is Allergy/Immunology billed $174.9M to Medicare fee-for-service in 2023.
Calendar year 2023 · Medicare fee-for-service Part B
You're viewing calendar year 2023. State market links open the latest data year.
On this page: Billing by state · Top codes
Medicare billing by state
| State | Standardized payments | Medicare payments | Groups | Pay / group | Services | Benef.-episodes | Svc / group |
|---|---|---|---|---|---|---|---|
| Florida | $24.8M | $24.7M | 33 | $748K | 1.9M | 54,613 | 58,855 |
| California | $18.4M | $19.3M | 40 | $482K | 917K | 72,208 | 22,919 |
| Arizona | $12.7M | $12.5M | 14 | $892K | 654K | 32,063 | 46,721 |
| Texas | $12.3M | $12.0M | 47 | $256K | 773K | 55,355 | 16,455 |
| Tennessee | $9.8M | $9.2M | 12 | $768K | 644K | 42,297 | 53,699 |
| Ohio | $9.3M | $9.1M | 13 | $696K | 367K | 19,261 | 28,237 |
| North Carolina | $9.1M | $8.7M | 11 | $795K | 443K | 53,221 | 40,242 |
| Pennsylvania | $6.0M | $6.0M | 22 | $275K | 287K | 28,078 | 13,037 |
| Virginia | $5.7M | $5.6M | 18 | $313K | 402K | 33,547 | 22,333 |
| Maryland | $5.4M | $5.6M | 14 | $400K | 249K | 21,497 | 17,803 |
| New York | $5.2M | $5.6M | 22 | $253K | 280K | 24,933 | 12,749 |
| Massachusetts | $5.0M | $5.2M | 18 | $287K | 265K | 23,679 | 14,720 |
| Georgia | $4.2M | $4.0M | 18 | $222K | 228K | 26,637 | 12,690 |
| Mississippi | $3.9M | $3.7M | 3 | $1.2M | 185K | 8,962 | 61,805 |
| Michigan | $3.8M | $3.7M | 35 | $107K | 235K | 22,243 | 6,723 |
| Oklahoma | $3.2M | $3.0M | 4 | $748K | 194K | 12,433 | 48,434 |
| Nebraska | $3.1M | $3.0M | 3 | $1.0M | 131K | 7,729 | 43,585 |
| South Carolina | $3.1M | $2.9M | 7 | $408K | 227K | 21,484 | 32,375 |
| Kentucky | $3.0M | $2.7M | 8 | $332K | 305K | 24,869 | 38,073 |
| Minnesota | $2.7M | $2.7M | 6 | $442K | 73,050 | 3,406 | 12,175 |
| Illinois | $2.7M | $2.7M | 20 | $137K | 147K | 13,989 | 7,332 |
| Kansas | $2.4M | $2.4M | 2 | $1.2M | 161K | 4,300 | 80,736 |
| Washington | $2.2M | $2.2M | 8 | $281K | 102K | 8,642 | 12,706 |
| Indiana | $2.2M | $2.0M | 8 | $254K | 179K | 11,669 | 22,435 |
| New Jersey | $2.2M | $2.3M | 12 | $193K | 128K | 14,115 | 10,707 |
| Colorado | $2.0M | $2.1M | 10 | $207K | 149K | 17,069 | 14,914 |
| Alabama | $1.6M | $1.5M | 8 | $190K | 58,872 | 4,760 | 7,359 |
| Louisiana | $1.5M | $1.5M | 11 | $133K | 79,780 | 5,792 | 7,253 |
| Missouri | $1.3M | $1.2M | 10 | $120K | 113K | 8,033 | 11,282 |
| Arkansas | $1.2M | $1.0M | 5 | $207K | 118K | 9,491 | 23,648 |
| Nevada | $1.1M | $1.1M | 7 | $152K | 90,711 | 8,411 | 12,959 |
| New Mexico | $880K | $823K | 4 | $206K | 57,040 | 9,846 | 14,260 |
| Idaho | $741K | $693K | 5 | $139K | 48,518 | 5,759 | 9,704 |
| Oregon | $615K | $608K | 8 | $76K | 45,155 | 4,635 | 5,644 |
| District of Columbia | $525K | $605K | 2 | $302K | 21,072 | 4,139 | 10,536 |
| West Virginia | $474K | $440K | 3 | $147K | 13,779 | 5,380 | 4,593 |
| Alaska | $367K | $403K | 4 | $101K | 20,041 | 2,608 | 5,010 |
| Connecticut | $322K | $346K | 6 | $58K | 29,232 | 3,255 | 4,872 |
| Utah | $310K | $294K | 2 | $147K | 21,009 | 1,828 | 10,504 |
| Hawaii | $294K | $306K | 3 | $102K | 15,491 | 2,611 | 5,164 |
| Wisconsin | $257K | $242K | 5 | $48K | 11,320 | 2,694 | 2,264 |
| Rhode Island | $210K | $213K | 2 | $107K | 20,098 | 2,151 | 10,049 |
| New Hampshire | $129K | $131K | 2 | $66K | 7,796 | 1,173 | 3,898 |
| Maine | $120K | $120K | 1 | $120K | 10,786 | 1,490 | 10,786 |
| Vermont | $100K | $96K | 1 | $96K | 8,217 | 1,314 | 8,217 |
| Delaware | $97K | $97K | 3 | $32K | 9,119 | 994 | 3,040 |
| Iowa | $91K | $81K | 2 | $41K | 8,767 | 954 | 4,384 |
| Montana | $82K | $81K | 2 | $41K | 7,033 | 790 | 3,516 |
| South Dakota | $50K | $48K | 1 | $48K | 4,822 | 475 | 4,822 |
| Wyoming | $12K | $12K | 1 | $12K | 879 | 249 | 879 |
| VI | $63 | $63 | 1 | $63 | 18 | 12 | 18 |
Need this specialty's market in one document?
Register your interestEach group carries one specialty label — the specialty most common among its clinicians in CMS's Doctors and Clinicians register — so every figure on this page counts groups, not individual clinicians. An organization's entire Medicare billing is credited to that one label, so a specialty's totals reflect how organizations are labeled, not the specialty of each service; large multi-specialty organizations — where no single specialty is a majority of the clinicians — account for much of the volume shown under many specialties. Totals include only volume that can be credited to a single group; clinicians registered with more than one group are left out of group totals and shown as “—” elsewhere on Nevvi. Clinicians not registered with any group, and groups without a specialty label, are also not included. A group is counted in every state its clinicians bill Medicare from, so state figures overlap and never sum to the national figure.
All figures are Medicare fee-for-service Part B only; Medicare Advantage claims are not included. Cross-state comparisons use standardized payments, which remove regional differences in what Medicare pays; services without a standardized amount — mainly Part B drugs — are not in that column, and the Medicare payments column shows what Medicare actually paid. Beneficiary counts are beneficiary-episodes: one person treated in more than one setting or state is counted in each.
Top codes by Medicare payments CY2023
8 more CPT-coded procedures — shown with a trial or subscription, under AMA licensing.
| Code | Medicare payments | Services | Largest state markets |
|---|---|---|---|
| J2357 · Injection, omalizumab, 5 mg | $43.9M | 1.5M | FLCAAZTXTN |
| J1556 · Injection, immune globulin (bivigam), 500 mg | $11.3M | 203K | FLCAAZTXTN |
| J0517 · Injection, benralizumab, 1 mg | $9.1M | 69,503 | FLCAAZTXTN |
| J2182 · Injection, mepolizumab, 1 mg | $5.5M | 239K | FLCAAZTXTN |
| J0717 · Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) top by services | $4.4M | 1.1M | FLCAAZTXTN |
| J2356 · Injection, tezepelumab-ekko, 1 mg top by services | $4.1M | 288K | FLCAAZTXTN |